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Summary
HIV-infected prisoners face an inordinate number of community re-entry challenges. In 2007, 102
HIV-infected prisoners in Malaysia were surveyed anonymously within six months prior to release
to assess the prevalence and correlates of community re-entry challenges. Staying out of prison
(60.8%), remaining off drugs (39.2%), finding employment (35.3%) and obtaining HIV care
(32.4%) were the re-entry challenges reported most frequently. Global stigma, negative self-image
and public attitudes-related stigma were independently associated with challenges to obtaining
HIV care. In multivariate analyses, those with previous incarcerations (adjusted odds ratio [AOR],
3.2; 95% confidence interval [CI], 1.4–7.6), higher HIV-related symptoms (AOR, 2.0; 95% CI,
1.0–4.1) and higher public attitudes-related stigma (AOR, 2.5; 95% CI, 1.2–5.1) had a
significantly higher likelihood of identifying more re-entry challenges. Targeted interventions,
such as effective drug treatment, HIV care and public awareness campaigns, are crucial for
stemming the HIV epidemic and improving health outcomes among HIV-infected prisoners in
Malaysia.
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BACKGROUND
The global magnitude of incarceration is staggering. During the past two decades, prison
populations around the world have steadily increased, and by the end of 2008, nearly 10
million people were incarcerated worldwide.1,2 Malaysia's imprisonment rate, which is one
of the highest in southeast Asia,2 is inextricably linked to its war on drugs. From 2001 to
2007, drug-related arrests increased from 21,000 to 54,000. This, coupled with the recent
introduction of mandatory sentences of two to five years for those who failed government-
sponsored drug treatment at compulsory drug treatment centres or had been convicted of
drug use more than twice, contributed to 16,237 prisoners or 38% of the total prison
population by the end of 2007.3
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Nearly all prisoners return to local communities, and therefore face a cascade of interrelated
challenges during their transition back into the community.4–6 Numerous factors, including
problems associated with obtaining employment,7 financial and poverty-related burdens,8,9
stable housing and transitional support,10–12 and reuniting with family and other support
networks,13 are just a few of the cited issues that contribute to re-incarceration. Re-entry
challenges are magnified for those who have significant medical co-morbidity; a
disproportionate number of prisoners are affected with a myriad of illnesses, including
mental illness, substance use disorders and infectious diseases such as HIV/AIDS, viral
hepatitis and tuberculosis.5,14–18 Disruptions in continuity of care, lack of health-care
coverage and resources, and high rates of drug and alcohol relapse thwart positive health and
social outcomes for both HIV-infected and non-infected prisoners.4,15,19–21
Infectious diseases such as HIV/AIDS pose special community re-entry issues globally.5
Not only are there considerable challenges in the continuity of HIV care,22 which when
discontinued leads to significant co-morbidity and mortality, but also results in heightened
risks for infection of others when risk reduction interventions are not provided.23 In
particular, the most common mode of transmission of HIV among prisoners is injection drug
use and there is scant evidence of effective treatments that successfully transitions HIV-
infected prisoners with substance use disorders back to the community.
In Malaysia, criminalization of drug use and a delayed public health response exacerbated
the growing HIV epidemic, particularly among injection drug users (IDUs).24 As a result,
75% of cumulative HIV/AIDS cases occurred among IDUs.25 In 2005, the government
recognized that it had not achieved a reduction in HIV/AIDS cases and rapidly implemented
syringe exchange26 and methadone maintenance programmes.27 Nevertheless, the
prevalence of HIV among 50,000 Malaysian prisoners, where HIV testing is mandatory, is
approximately 6%;16 this is 15 times greater than that found in the general adult population
where it is 0.4%.25 As a consequence, HIV-infected prisoners in Malaysia represent a
critical group for targeted intervention, yet their community re-entry challenges have not
been assessed. Therefore, the objective of this study was to identify the prevalence and
correlates of community re-entry challenges faced by HIV-infected male prisoners prior to
transition from prison back into the community.
METHODS
Study setting
This study was conducted in June 2007 at Pengkalan Chepa Prison, a male correctional
facility in Kota Bharu, Malaysia. Kota Bharu, situated near the Thailand–Malaysia border, is
the capital of Kelantan, one of the poorest states in Malaysia.28 As is the case throughout
Malaysia, all prison inmates at the prison undergo mandatory HIV testing and HIV-infected
prisoners are segregated in dormitory settings.
Study subjects
Study eligibility included being HIV-infected and being within six months of community
release. Prison officials queried the prison database and provided a list of 102 individuals
who met eligibility criteria to a medical practitioner. The practitioner subsequently asked
each eligible inmate if he was interested in participating in an anonymous survey about
making plans for transition back to the community. Interested inmates were referred to a
member of the study team who described in private the nature of the study, obtained written
consent and conducted the 30-minute interview. All 102 referred inmates agreed to
participate. No names or unique identifiers were collected, nor were coercive incentives or
disincentives provided. All interviews were conducted in Bahasa Malaysia by trained,
Choi et al. Page 2
Int J STD AIDS. Author manuscript; available in PMC 2010 August 23.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
bilingual interviewers from the University of Malaya. All procedures and data collection
forms for this study were reviewed and approved by the Medical Ethics Committee at the
University of Malaya Medical Centre.
Study measures
Structured interviews included demographic information, drug use and re-entry challenges,
as well as standardized and validated scales measuring HIV stigma29 and HIV symptoms.30
Opioid dependence was defined if the subject reported the persistent use of heroin or any
other known opioid during the 12 months prior to the current incarceration and met at least
three of seven standardized criteria for opioid dependence. A list of re-entry challenges was
created from a review of the existing literature and discussion with local experts; those
included in this study were staying out of prison, remaining off drugs, finding employment,
obtaining HIV care, getting financial support from family, finding adequate housing and
reuniting with family or friends. For each re-entry task, a 5-point Likert scale was used to
determine the level of difficulty; a re-entry challenge was identified if the task was
perceived as `hard' or `very hard'. The questionnaire was created in English and translated
and back-translated into Bahasa Malaysia by trained English/Bahasa Malaysia bilingual
interviewers.31
DATA ANALYSIS
Data analysis was done using SAS, version 9.1.3 (SAS Institute Inc, Cary, NC, USA).
Descriptive statistics were generated by conducting frequencies on all predictor variables
and re-entry challenges. Demographic and social circumstances were measured as
categorical variables, but were further collapsed into fewer levels because of small
frequencies in some categories. All items from the Berger HIV Stigma Scale were measured
using the original 4-point Likert scale. All 20 items from the HIV Symptom Index were
measured according to whether or not a subject indicated having the symptom. Stigma, HIV-
related symptoms and age were dichotomized as being high or low relative to the median.
Previous incarcerations and previous detentions in rehabilitation centres were dichotomized
into `none' and `any' since a large percentage of the sample reported never having had both
(24.5% and 46.1%, respectively). Responses to the remaining variables were measured
dichotomously.
Bivariate associations between the predictor variables and the outcome variables were
conducted using the Pearson's chi-square test or Fisher's exact test as appropriate. For
multivariate analyses, an ordinal outcome variable representing the total number of re-entry
challenges reported was created and proportional odds logistic regression was used. The
odds ratios (OR) and 95% confidence intervals (CI) presented are estimates of the likelihood
of reporting a greater number of re-entry challenges. A P value of 0.10 was used to enter the
multivariate model, and variables significant at the 0.05 level were retained. A backward
elimination strategy was used to determine the most parsimonious set of predictors. The
proportional odds assumption for the final multivariate model was met.
RESULTS
Table 1 describes the baseline characteristics of the subjects. The mean age was 33.0 years
with the majority reporting being Malay (96.1%), not married (81.4%), opioid-dependent
(81.4%), living with family prior to the present incarceration (87.3%), having had a family
visit while currently incarcerated (75.0%) and having been previously incarcerated (75.5%;
mean = 2.5±2.3, range = 0–10 times). Approximately half the sample had previous
detentions in a rehabilitation centre (53.9%; mean = 1.1±1.4, range = 0–6 times) and
reported ≥7 HIV-related symptoms (52.0%; mean = 7.1±3.7, range = 0–17). Nearly two-
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thirds reported having known someone close who died of AIDS (65.7%), while less than
half had provided care for someone with HIV/AIDS (42.2%). While the entire sample was
HIV-infected, only two subjects reported having ever been prescribed antiretroviral
medications.
In this sample: total stigma scores ranged from 69 to 125 (mean = 99.1±9.7); personalized
stigma subscale scores ranged from 31 to 55 (mean = 43.9±5.2); disclosure stigma subscale
scores ranged from 16 to 34 (mean = 26.1±2.9); negative self-image stigma subscale scores
ranged from 21 to 44 (mean = 32.4±3.5); and public attitudes stigma subscale scores ranged
from 37 to 65 (mean = 49.0±5.6).
Figure 1 depicts the proportion of the sample that identified re-entry challenges. Staying out
of prison was the most prevalent challenge (60.8%) facing this sample, followed by
remaining off drugs (39.2%). Roughly one-third of the sample reported difficulty finding
employment (35.3%), obtaining HIV care (32.4%) and getting financial support from family
(29.4%). A smaller proportion, 13.7% and 8.8%, respectively, identified difficulty finding
adequate housing and reuniting with friends.
Bivariate associations between predictor variables and re-entry challenges are represented in
Table 2. Lower education level was associated with difficulty obtaining financial support
from family (P = 0.004) and reuniting with friends (P = 0.008). Previous incarceration was
associated with difficulty staying out of prison (P = 0.004). High numbers of HIV-related
symptoms were associated with difficulty finding employment (P = 0.006) and getting
financial support from family (P = 0.04). High levels of stigma, including negative self-
image and public attitudes stigma, were associated with difficulty obtaining HIV care (P =
0.05, P = 0.02 and P = 0.0005, respectively). A low disclosure stigma subscale score was
associated with difficulty staying out of prison (P = 0.05). Although these did not quite
approach significance, those who were not married, were previously incarcerated, had a
higher number of HIV-related symptoms, and had higher total stigma and public attitudes
stigma scores expressed difficulty with achieving at least six out of the seven re-entry tasks.
Bivariate and multiple ordinal logistic regression results are depicted in Table 3. In the
bivariate analysis, those who had previous incarcerations, high number of HIV-related
symptoms, high negative self-image stigma subscale scores and high public attitudes stigma
scores had a significantly higher likelihood of identifying a greater number of re-entry
challenges. In the multiple logistic regression analysis, the outcomes were similar to the
bivariate findings except that levels of negative self-image stigma no longer remained
significant.
DISCUSSION
To our knowledge, this is the first investigation assessing the community re-entry challenges
faced by HIV-infected male prisoners in Malaysia. Remaining out of prison, staying off
drugs, finding employment and obtaining HIV care emerged as the most prevalent re-entry
challenges.
The findings from this prison-derived sample have important implications broadly for the
HIV epidemic in Malaysia, as these prisoners are highly representative of the group most
predominantly affected by the epidemic in this country – young, injection drug-using ethnic
Malay males.25 The stated re-entry challenges themselves were not too dissimilar from those
generally reported by prisoners, and the magnitude of individuals identifying these
challenges was often lower than expected, consistent with the unrealistic optimism of
prisoners towards their post-release success that has been reported elsewere.32–34 For
instance, 61% stated that staying out of prison would be a challenge, yet an even higher
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percentage of the sample had been incarcerated many times previously. Although it is well-
established that prior incarceration is a risk factor for re-incarceration,8,35 including among
HIV-infected individuals,36 the cognitive dissonance in recognizing this association was
striking.
As further evidence of this dissonance, one-third of the subjects expressed concern for
obtaining HIV care upon release. This finding is surprising, especially among a sample that
reported a significant burden of HIV-related symptoms, presumably because of more
advanced HIV disease, and for whom only 2% had ever been prescribed antiretroviral
therapy successfully. These results, however, are consistent with previously documented
inequities in HIV care for drug users in Malaysia, where only 2% of 315 patients receiving
antiretroviral treatment in a publicly funded hospital were IDUs.37 The reality facing the
vast majority of IDUs in Malaysia and in other parts of the world is that while they are
among the most at risk and affected by HIV/AIDS, they are also among the least likely to
receive antiretroviral medications.38,39
The results from this study offer several insights into why disparities in access to care may
exist for this population. First, stigma, especially negative self-image and public disclosure,
plays an important role among IDUs in Malaysia obtaining HIV care or perceiving it to be a
re-entry challenge. Mounting research confirms the widespread, persistent and debilitating
nature of HIV-related stigma, including in southeast Asia.40,41 Several practices in Malaysia
may contribute to the persistence of high public attitudes stigma. For instance, Muslim
burial rites require that the body be thoroughly cleansed, and according to public health
laws, this must be supervised by police or local health officials. Cleansing is done with
bleach for people who are known to be infected with HIV; in rural areas, particularly, this
practice threatens to single out families for having had an HIV-infected relative.42
Additionally, HIV contact tracing traditionally involved public health officers making home
visits to inform families that they had been exposed to an HIV-infected individual, again
reinforcing the societal and individual anxiety and stigma towards HIV/AIDS. In this
sample, high public attitudes stigma was significantly associated with identifying difficulty
with finding employment and obtaining HIV care. After adjusting for any previous
incarcerations and the high number of HIV-related symptoms reported, those reporting high
levels of public attitudes stigma were about three times more likely to identify a greater
number of re-entry challenges compared with those with low scores. An element of the
perception of high public attitudes stigma related to HIV may also be the stigma of being an
ex-prisoner.43,44 As a result, HIV-infected prisoners may be disadvantaged in their ability to
overcome their re-entry challenges due to the compound stigma they perceive. For instance,
stigma in health-care settings can be expressed through breaches of confidentiality,
substandard levels of care, refusal to offer services and other forms of discriminatory care.
40,41,45 Stigma that is internalized, regardless of the source, can lead to perceptions of
unworthiness, shame, guilt and other forms of negative self-image that can complicate
efforts towards HIV-treatment-seeking behaviors.29,46,47
Malaysia is now experiencing the kind of stigmatization of HIV-infected marginalized
groups that first unfolded three decades ago in the USA.48 Apart from moral judgement,
HIV stigma within Malaysian society is largely rooted in the fear of transmission and
infection, which has persisted despite past awareness campaigns that HIV cannot be spread
by casual and household contact.49 Therefore, novel interventions are needed within the
Malaysian context at both the individual and the societal levels to mitigate HIV-related
stigma. Guidelines and examples of successful programmes have already been established,
including public awareness campaigns of transformation of HIV/AIDS into a chronic but
treatable condition.50
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Paradoxically, high levels of disclosure stigma did not emerge as a significant correlate of
more re-entry challenges. This is surprising, given what is known about the perceived risks
and benefits of the decision to disclose one's HIV status in other settings.41,51,52 On the
other hand, a greater proportion of those with low levels of disclosure stigma identified
difficulty with staying out of prison. Since HIV testing is mandatory upon entry into
Malaysian prisons and the majority of subjects in this study had been incarcerated multiple
times, these individuals may have perceived less stigma in disclosing their HIV status;
however, due to their history of prior incarceration, they may have also been more aware of
the difficulties they were likely to face in avoiding future incarceration. It is also surprising
that social support indicators, such as having lived with family prior to incarceration or
family visits during incarceration, were not significantly associated with identifying fewer
re-entry challenges.
In addition to stigma, limited interaction between HIV-infected prisoners and HIV care
providers further contributes to inequities in access to care for this population. The lack of
interface with appropriate HIV care likely contributed to the low prevalence of identifying
difficulty obtaining HIV care in this sample, precisely because these individuals may not be
aware of the HIV treatment options available to them or because of the well-known
difficulties in obtaining care. Given that high-risk drug and sexual behaviours often continue
during53 and after38 incarceration, placing HIV-infected prisoners and their partners54,55 at
continued risk for negative health outcomes, it is critical to link HIV-infected prisoners to
comprehensive transitional or case management programmes that include HIV and drug
treatment services.22
In this study sample, the magnitude of individuals identifying drug treatment as a re-entry
challenge also seemed disproportionately low compared with those meeting criteria for
opioid dependence. Specifically, 81% met criteria for opioid dependence, a chronic and
relapsing disease, yet only 39% reported remaining drug-free as a challenge. It is unclear
whether the disconnect between the perceived versus the real need arose from the lack of
knowledge concerning effective and newly available pharmacotherapy for the treatment of
opioid dependence or the false perception that forced abstinence in prison was effective
treatment. Either way, these individuals are at high risk for relapse. Public awareness efforts
are urgently needed to facilitate knowledge about opioid dependence as a treatable medical
condition, potentially by using methadone or buprenorphine. Such evidence-based treatment
modalities have the added benefit of reducing recidivism, the highest ranking re-entry
challenge, as well as reducing high-risk HIV behaviours, and improving adherence to HIV
and antiretroviral therapy outcomes.5,56–60
At the multivariate level, previous incarcerations, high levels of HIV symptoms and high
levels of public attitudes stigma were independently associated with identifying more re-
entry challenges. Interventions that reduce the risk of incarceration, perhaps through
provision of employment and assistance with drug relapse-prevention (e.g. methadone
maintenance), may be especially helpful for this population. HIV treatment, particularly
given the high degree of HIV symptoms found in this sample, is profoundly deficient for
transitioning prisoners. Unmanaged HIV-related symptoms can reduce prisoners' capacity to
engage in the routine tasks that are critical to the success of their long-term reintegration into
the community. In this sample, for example, a high number of HIV-related symptoms were
found to be associated with difficulty finding employment and getting financial support
from family at the bivariate level. Thus, finding ways to effectively link these individuals to
effective HIV care is urgently needed to reduce their symptoms and get them back into the
workforce.
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This study had several limitations. The small sample size and single study site may have
reduced the power to detect a greater number of significant associations and the
generalisability of the results to all HIV-infected prisoners, respectively. It is also unclear to
what extent the perceived difficulties associated with specific re-entry tasks translated into
actual difficulties after the subject was released since follow-up analyses were not
conducted. Moreover, the cross-sectional nature of the study does not determine causality
and confers only an association that must be addressed in prospective, longitudinal studies.
Nevertheless, this study provides important insight into community re-entry challenges that
HIV-infected male prisoners in Malaysia face upon release, and offers critical insight into
potential areas of need for future intervention.
The findings from this study demonstrate that the most prevalent re-entry challenges
identified by this sample of HIV-infected, opioid-dependent male prisoners in Malaysia are
consistent with the challenges faced by their counterparts around the globe: remaining out of
prison, staying off drugs, finding employment and obtaining HIV care. At the same time,
however, many of the individuals in this study who met criteria for opioid dependence,
frequent recidivism and high HIV symptom indices did not identify these issues as re-entry
challenges. It is therefore critical that future evidence-based interventions focus on both
treatment and education in order to properly address the re-entry challenges faced by this
population.
Acknowledgments
The authors would like to thank the University of Malaya Research University Grant 2007 for their funding for
these clinical and research efforts as well as the National Institute on Drug Abuse for research (R01 DA025943,
Altice) and career development support (K24 DA017072, Altice).
REFERENCES
1. Walmsley, R. Global Incarceration and Prison Trends. Forum on Crime and Society. UNODC;
Vienna: 2003. p. 65-78.
2. Walmsley, R. World Prison Population List. 8th edn.. International Centre for Prison Studies; King's
College London: 2009.
3. National Anti-Drug Agency. Drug Report 2007. Ministry of Home Affairs; Malaysia: 2007.
4. Seal D, Eldrige G, Kacanek D, Binson D, Macgowan R. A longitudinal, qualitative analysis of the
context of substance use and sexual behavior among 18- to 29-year-old men after their release from
prison. Soc Sci Med 2007;65:2394–406. [PubMed: 17683839]
5. UNODC/WHO/UNAIDS. HIV/AIDS Prevention, Care, Treatment and Support in Prison Settings.
UNODC; Vienna: 2006.
6. Springer S, Altice F. Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep
2005;2:165–70. [PubMed: 16343373]
7. Uggen C, Staff J. Work as a turning point for criminal offenders. Corrections Manage Q 2001;5:1–
16.
8. Freudenberg N, Daniels J, Crum M, Perkins T, Richie B. Coming home from jail: the social and
health consequences of community reentry for women, male adolescents, and their families and
communities. Am J Public Health 2008;98:S191–202. [PubMed: 18687613]
9. Needels KE. Go directly to jail and do not collect? A long-term study of recidivism, employment,
and earnings among prison releasees. J Res Crime Delinquency 1996;33:471–96.
10. Lanier M, Paoline EA 3rd. Expressed needs and behavioral risk factors of HIV-positive inmates.
Int J Offender Ther Comp Criminol 2005;49:561–73. [PubMed: 16260483]
11. Roman CG. A roof is not enough: successful prisoner reintegration requires experimentation and
collaboration. Criminol Public Policy 2006;3:161–8.
Choi et al. Page 7
Int J STD AIDS. Author manuscript; available in PMC 2010 August 23.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
12. LaVigne, NG.; Wolf, SJ.; Jannetta, J. Voices of Experience: Focus Group Findings on Prisoner
Reentry in the State of Rhode Island. Urban Institute Justice Policy Center; Washington, DC:
2004.
13. LaVigne, NG.; Visher, C.; Castro, J. Chicago Prisoners' Experiences Returning Home. Urban
Institute Justice Policy Center; Washington, DC: 2004.
14. Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status,
homelessness, and incarceration. Public Health Rep 2002;117:S135–45. [PubMed: 12435837]
15. Belenko S. Assessing released inmates for substance-abuse-related service needs. Crime
Delinquency 2006;52:94–113.
16. Dolan K, Kite B, Black E, Aceijas C, Stimson G. HIV in prison in low-income and middle-income
countries. Lancet Infect Dis 2007;7:32–41. [PubMed: 17182342]
17. Pearson F, Cleland C, Chaple M, Hamilton Z, Prendergast M, Rich J. Substance use, mental health
problems, and behavior at risk for HIV: evidence from CJDATS. J Psychoactive Drugs
2008;40:459–69. [PubMed: 19283950]
18. Wilper AP, Woolhandler S, Boyd JW, et al. The health and health care of US prisoners: results of a
nationwide survey. Am J Public Health 2009;99:666–72. [PubMed: 19150898]
19. Cooke C. Joblessness and homelessness as precursors of health problems in formerly incarcerated
African American men. J Nurs Scholarsh 2004;36:155–60. [PubMed: 15227763]
20. Jarrett N, Adeyemi S, Huggins T. Bridging the gap: providing health care to newly released men. J
Health Care Poor Underserved 2006;17:70–80. [PubMed: 16520514]
21. van Olphen J, Freudenberg N, Fortin P, Galea S. Community reentry: perceptions of people with
substance use problems returning home from New York City jails. J Urban Health 2006;83:372–
81. [PubMed: 16739041]
22. Springer S, Pesanti E, Hodges J, Macura T, Doros G, Altice F. Effectiveness of antiretroviral
therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after
release to the community. Clin Infect Dis 2004;38:1754–60. [PubMed: 15227623]
23. Glaser J, Greifinger R. Correctional health care: a public health opportunity. Ann Intern Med
1993;118:139–45. [PubMed: 8416310]
24. Mazlan M, Schottenfeld RS, Chawarski MC. New challenges and opportunities in managing
substance abuse in Malaysia. Drug Alcohol Rev 2006;25:473–8. [PubMed: 16939945]
25. UNGASS. UNGASS Country Progress Report. Malaysia: 2008.
26. Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the challenges and responses.
Int J Drug Policy 2007;18:136–40. [PubMed: 17689356]
27. Noordin N, Merican M, Rahman H, Lee S, Ramly R. Substitution treatment in Malaysia. Lancet
2008;372:1149–50. [PubMed: 18926274]
28. Leete, R. Kelantan's Human Development Progress and Challenges. UNDP; Kuala Lumpur: 2004.
29. Berger B, Ferrans C, Lashley F. Measuring stigma in people with HIV: psychometric assessment
of the HIV stigma scale. Res Nurs Health 2001;24:518–29. [PubMed: 11746080]
30. Justice A, Holmes W, Gifford A, et al. Development and validation of a self-completed HIV
symptom index. J Clin Epidemiol 2001;54:S77–90. [PubMed: 11750213]
31. Glaser, BG.; Strauss, A. The Discovery of Grounded Theory: Strategies for Qualitative Research.
Aldine Transaction; Chicago: 1967.
32. Burnett R, Maruna S. So `prison works', does it? The criminal careers of 130 men released from
prison under Home Secretary, Michael Howard. Howard J Crim Justice 2004;43:390–404.
33. Dhami M, Mandel D, Loewenstein G, Ayton P. Prisoners' positive illusions of their post-release
success. Law Human Behav 2006;30:631–47.
34. Visher, C.; LaVigne, N.; Farrell, J. Illinois Prisoners' Reflections on Returning Home. The Urban
Institute; Washington, DC: 2003.
35. Rich J, Holmes L, Salas C, et al. Successful linkage of medical care and community services for
HIV-positive offenders being released from prison. J Urban Health 2001;78:279–89. [PubMed:
11419581]
Choi et al. Page 8
Int J STD AIDS. Author manuscript; available in PMC 2010 August 23.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
36. Marlow E, White M, Tulsky J, Estes M, Menendez E. Recidivism in HIV-infected incarcerated
adults: influence of the lack of a high school education. J Urban Health 2008;85:585–95.
[PubMed: 18418714]
37. Kamarulzaman, A. Antiretroviral therapy in HIV-infected patients in Kuala Lumpur, Malaysia.
15th Annual Conference of the Australasian Society for HIV Medicine: Global Crisis, Global
Action; Cairns, Australia. 2003.
38. Aceijas C, Oppenheimer E, Stimson G, Ashcroft R, Matic S, Hickman M. Antiretroviral treatment
for injecting drug users in developing and transitional countries 1 year before the end of the
`Treating 3 million by 2005. Making it happen. The WHO strategy' (`3 by 5'). Addiction
2006;101:1246–53. [PubMed: 16911723]
39. Celentano D, Vlahov D, Cohn S, Shadle V, Obasanjo O, Moore R. Self-reported antiretroviral
therapy in injection drug users. JAMA 1998;280:544–6. [PubMed: 9707145]
40. Busza J. Promoting the positive: responses to stigma and discrimination in Southeast Asia. AIDS
Care 2001;13:441–56. [PubMed: 11454265]
41. Paxton S. The paradox of public HIV disclosure. AIDS Care 2002;14:559–67. [PubMed:
12204158]
42. AIDS/STI Unit. Guidelines for Muslim Burial Rites from a Health Perspective. 2nd edn.. Ministry
of Health Malaysia; Petaling: 2002.
43. Pager D. The mark of a criminal record. Am J Sociol 2003;108:937–75.
44. Uggen, C.; Manza, J.; Behrens, A. Less than the Average Citizen: Stigma, Role Transition, and the
Civic Reintegration of Convicted Felons. Willan Publishing; Cullompton, Devon: 2004.
45. Ogden, J.; Nyblade, L. Common at its Core: HIV-related Stigma Across Contexts. International
Center for Research on Women; Washington, DC: 2005.
46. Lee RS, Kochman A, Sikkema KJ. Internalized stigma among people living with HIV-AIDS.
AIDS Behav 2002;6:309–19.
47. Vanable P, Carey M, Blair D, Littlewood R. Impact of HIV-related stigma on health behaviors and
psychological adjustment among HIV-positive men and women. AIDS Behav 2006;10:473–82.
[PubMed: 16604295]
48. Novick A. Stigma and AIDS: three layers of damage. J Gay Lesbian Med Assoc 1998;1:53–60.
49. Zulkifli, SN.; Huang, SL.; Low, W.; Wong, YL. Study on the Impact of HIV on People Living
with HIV, their Families and Community in Malaysia Project Report. United Nations Country
Team on HIV/AIDS; Malaysia: 2006.
50. UNAIDS. Reducing HIV Stigma and Discrimination: A Critical Part of National AIDS
Programmes. Joint United Nations Programme on HIV/AIDS; Geneva: 2007.
51. Parson JT, Vanora J, Missildine W, Purcell DW, Gomez CA. Positive and negative consequences
of HIV disclosure among seropositive injection drug users. AIDS Educ Prev 2004;16:459–75.
[PubMed: 15491957]
52. Chesney MA, Smith AW. Critical delays in HIV testing and care: the potential role of stigma. Am
Behav Sci 1999;42:1162–7.
53. Dolan K, Wodak A, Hall W. A bleach program for inmates in NSW: an HIV prevention strategy.
Aust N Z J Public Health 1998;22:838–40. [PubMed: 9889456]
54. Stephenson B, Wohl D, McKaig R, et al. Sexual behaviours of HIV-seropositive men and women
following release from prison. Int J STD AIDS 2006;17:103–8. [PubMed: 16464271]
55. Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke J, Flanigan T. Human
immunodeficiency virus in correctional facilities: a review. Clin Infect Dis 2002;35:305–12.
[PubMed: 12115097]
56. Stallwitz A, Stöver H. The impact of substitution treatment in prisons – a literature review. Int J
Drug Policy 2007;18:464–74. [PubMed: 18061872]
57. Lawrinson P, Ali R, Buavirat A, et al. Key findings from the WHO collaborative study on
substitution therapy for opioid dependence and HIV/AIDS. Addiction 2008;103:1484–92.
[PubMed: 18636999]
58. Larney S, Dolan K. A literature review of international implementation of opioid substitution
treatment in prisons: equivalence of care? Eur Addict Res 2009;15:107–12. [PubMed: 19182485]
Choi et al. Page 9
Int J STD AIDS. Author manuscript; available in PMC 2010 August 23.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
59. Smith-Rohrberg D, Bruce RD, Altice F. Review of corrections-based therapy for opiate-dependent
patients: implications for buprenorphine treatment among correctional populations. J Drug Issues
2004;34:451–80.
60. Keen J, Rowse G, Mathers N, Campbell M, Seivewright N. Can methadone maintenance for
heroin-dependent patients retained in general practice reduce criminal conviction rates and time
spent in prison? Br J Gen Pract 2000;50:48–9. [PubMed: 10695069]
Choi et al. Page 10
Int J STD AIDS. Author manuscript; available in PMC 2010 August 23.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
Proportion of subjects identifying community re-entry challenges
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Table 1
Characteristics of subjects (n = 102)
Characteristic n %
Age (years)
<33 51 50.0
≥33 51 50.0
Ethnicity
Malay 98 96.1
Other* 4 3.9
Education †
Primary 21 20.6
Lower secondary 46 45.1
Higher secondary or higher 35 34.3
Marital status
Not married‡ 83 81.4
Married 19 18.6
Living arrangement prior to incarceration
With family 89 87.3
Other§ 13 12.7
Previous incarcerations
None 25 24.5
Any 77 75.5
Previous detentions in rehabilitation centre
None 47 46.1
Any 55 53.9
Family visits during incarceration
No 25 24.5
Yes 77 75.5
Provided care for someone living with HIV/AIDS
No 59 57.8
Yes 43 42.2
Knew someone close who died of AIDS
No 35 34.3
Yes 67 65.7
Ever prescribed antiretroviral medications
No 100 98.0
Yes 2 2.0
Number of HIV-related symptoms (median = 7)**
Low 50 49.0
High 52 51.0
Opioid-dependent
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Characteristic n %
No 19 18.6
Yes 83 81.4
Total stigma score (median = 97) ††
Low 48 47.1
High 54 52.9
Personalized stigma subscale score (median = 42) ††
Low 41 40.2
High 61 59.8
Disclosure stigma subscale score (median = 26) ††
Low 43 42.2
High 59 57.8
Negative self-image stigma subscale score (median = 32) ††
Low 45 44.1
High 57 55.9
Public attitudes stigma subscale score (median = 48) ††
Low 50 49.0
High 52 51.0
*
Other = Indian, Chinese, mixed or other
†
Indicates highest level of education attained. Primary is up to Grade 6, lower secondary is up to Grade 9, higher secondary or higher is up to
Grade 12 or university
‡
Not married = single, separated or widowed
§
Other = reported living alone, with friends, in a hostel or homeless/on the streets
**
Derived from the HIV Symptom Index
††
Derived from the Berger HIV Stigma Scale
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Table 3
Bivariate and adjusted ordinal logistic regression results
Odds ratio (95% CI)
Characteristic Bivariate Adjusted
Age ≥33 0.8 (0.4–1.6) -
Education
 Lower secondary 0.9 (0.4–2.3) -
 Higher secondary or higher 0.7 (0.3–1.7) -
Married 0.6 (0.3–1.5) -
Lived with family prior to incarceration 1.3 (0.5–3.7) -
Previous incarcerations 3.3 (1.4–7.7)* 3.2 (1.4–7.6)*
Previous detentions in a rehabilitation centre 1.8 (0.9–3.6) -
Family visits during incarceration 0.8 (0.4–1.9) -
Provided care for someone living with HIV/AIDS 1.0 (0.5–2.1) -
Knew someone close who died of AIDS 1.3 (0.6–2.6) -
Number of HIV-related symptoms ≥7 2.1 (1.0–4.2)* 2.0 (1.0–4.1)*
Opioid-dependent 1.3 (0.5–3.1) -
Total stigma score ≥97 1.8 (0.9–3.6) -
Personalized stigma subscale score ≥42 1.6 (0.8–3.2) -
Disclosure stigma subscale score ≥26 1.2 (0.6–2.4) -
Negative self-image stigma subscale score ≥32 2.2 (1.1–4.5)* -
Public attitudes stigma subscale score ≥48 3.0 (1.4–6.1)* 2.5 (1.2–5.1)*
*
P< 0.05
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